Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns

Citation
Y. Morice et al., Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns, J GEN VIROL, 82, 2001, pp. 1001-1012
Citations number
47
Categorie Soggetti
Microbiology
Journal title
JOURNAL OF GENERAL VIROLOGY
ISSN journal
00221317 → ACNP
Volume
82
Year of publication
2001
Part
5
Pages
1001 - 1012
Database
ISI
SICI code
0022-1317(200105)82:<1001:PACTHP>2.0.ZU;2-2
Abstract
Hepatitis C virus (HCV) has been classified into six clades as a result of high genetic variability. In the Seine-Saint-Denis district of north-east P aris, the prevalence of HCV-4, which usually infects populations from Afric a or the Middle East, is twice as high as that recorded for the whole of co ntinental France(102 versus 4.5%). Although the pathogenicity of HCV-4 rema ins unknown, resistance of HCV-4 to therapy appears to be similar to that o bserved for HCV-1. In order to characterize the epidemiology of HCV-4 in Pa ris, sequences of the non-structural 5B gene (332 bp) were obtained from 38 HCV-4-infected patients. Extensive phylogenetic analyses indicated seven d ifferent HCV-4 subtypes. Moreover, phylogenetic tree topologies clearly dis tinguished two epidemiological profiles. The first profile (52.6% of patien ts) reflects the intra-suburban emergence of two distinct HCV-4 subclades o ccurring mainly among intravenous drug users (65% of patients). The second profile shows six subclades [HCV-4a, -4f, -4h, -4k, -4a(B) and a new sequen ce] and accounts for patients from Africa (Egypt and sub-Saharan countries) who have unknown risk factors (77.8% of patients) and in whom no recent di ffusion of HCV-4 is evident. This study indicates the high diversity of HCV -4 and the extension of HCV-4a and -4d subclades among drug users in France .